Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.4.6.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CM.7.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.3.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.22NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.7.19NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FA.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
KB.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
HF.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BG.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.1.42.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.517NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.427 (Epsilon)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.429 (Epsilon)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.166NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.4.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
A.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.86NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.154NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.4.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
A.2.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.41NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.137NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.446NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.76 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.398NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.163NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.3 (Theta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.254NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.39.1.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.418NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.9.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.40NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.122NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAJNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.431NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.168NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Q.6 (Alpha)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AZ.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.97NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.18NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.32NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.59NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
B.1.177.67NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.277NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
AY.28 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.272NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.371NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AA.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.353NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used